Skip to main content
Journal cover image

Hyperbaric oxygen therapy to prevent central airway stenosis after lung transplantation.

Publication ,  Journal Article
Kraft, BD; Mahmood, K; Harlan, NP; Hartwig, MG; Snyder, LD; Suliman, HB; Shofer, SL
Published in: J Heart Lung Transplant
April 2021

BACKGROUND: Central airway stenosis (CAS) is a severe airway complication after lung transplantation associated with bronchial ischemia and necrosis. We sought to determine whether hyperbaric oxygen therapy (HBOT), an established treatment for tissue ischemia, attenuates post-transplant bronchial injury. METHODS: We performed a randomized, controlled trial comparing usual care with HBOT (2 atm absolute for 2 hours × 20 sessions) in subjects with extensive airway necrosis 4 weeks after transplantation. Endobronchial biopsies were collected at 4, 7, and 10 weeks after transplantation for a quantitative polymerase chain reaction. Coprimary outcomes were incidence of airway stenting and acute cellular rejection (ACR) at 1 year. RESULTS: The trial was stopped after enrolling 20 subjects (n = 10 per group) after a pre-planned interim analysis showed no difference between usual care and HBOT groups in stenting (both 40%), ACR (70% and 40%, respectively), or CAS (40% and 60%, respectively). Time to first stent placement (median [interquartile range]) was significantly shorter in the HBOT group (150 [73-150] vs 186 [167-206] days, p < 0.05). HIF gene expression was significantly increased in donor tissues at 4, 7, and 10 weeks after transplantation but was not altered by HBOT. Subjects who developed CAS or required stenting had significantly higher HMOX1 and VEGFA expression at 4 weeks (both p < 0.05). Subjects who developed ACR had significant FLT1, TIE2, and KDR expression at 4 weeks (all p < 0.05). CONCLUSIONS: Incidence of CAS is high after severe, established airway necrosis after transplantation. HBOT does not reduce CAS severity or stenting. Elevated HMOX1 and VEGFA expressions appear to associate with airway complications.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Heart Lung Transplant

DOI

EISSN

1557-3117

Publication Date

April 2021

Volume

40

Issue

4

Start / End Page

269 / 278

Location

United States

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Surgery
  • Postoperative Complications
  • Middle Aged
  • Male
  • Lung Transplantation
  • Hyperbaric Oxygenation
  • Humans
  • Graft Rejection
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kraft, B. D., Mahmood, K., Harlan, N. P., Hartwig, M. G., Snyder, L. D., Suliman, H. B., & Shofer, S. L. (2021). Hyperbaric oxygen therapy to prevent central airway stenosis after lung transplantation. J Heart Lung Transplant, 40(4), 269–278. https://doi.org/10.1016/j.healun.2021.01.008
Kraft, Bryan D., Kamran Mahmood, Nicole P. Harlan, Matthew G. Hartwig, Laurie D. Snyder, Hagir B. Suliman, and Scott L. Shofer. “Hyperbaric oxygen therapy to prevent central airway stenosis after lung transplantation.J Heart Lung Transplant 40, no. 4 (April 2021): 269–78. https://doi.org/10.1016/j.healun.2021.01.008.
Kraft BD, Mahmood K, Harlan NP, Hartwig MG, Snyder LD, Suliman HB, et al. Hyperbaric oxygen therapy to prevent central airway stenosis after lung transplantation. J Heart Lung Transplant. 2021 Apr;40(4):269–78.
Kraft, Bryan D., et al. “Hyperbaric oxygen therapy to prevent central airway stenosis after lung transplantation.J Heart Lung Transplant, vol. 40, no. 4, Apr. 2021, pp. 269–78. Pubmed, doi:10.1016/j.healun.2021.01.008.
Kraft BD, Mahmood K, Harlan NP, Hartwig MG, Snyder LD, Suliman HB, Shofer SL. Hyperbaric oxygen therapy to prevent central airway stenosis after lung transplantation. J Heart Lung Transplant. 2021 Apr;40(4):269–278.
Journal cover image

Published In

J Heart Lung Transplant

DOI

EISSN

1557-3117

Publication Date

April 2021

Volume

40

Issue

4

Start / End Page

269 / 278

Location

United States

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Surgery
  • Postoperative Complications
  • Middle Aged
  • Male
  • Lung Transplantation
  • Hyperbaric Oxygenation
  • Humans
  • Graft Rejection